BANGKOK (Reuters) - Thai drugmaker Siam Bioscience, owned by the country's king, reported a near 50-fold increase in annual profit in 2021, when it began producing AstraZeneca Plc's COVID-19 vaccine, ...

BANGKOK (Reuters) - A Thai court has ordered a leading government foe to remove allegations on social media that the state's coronavirus vaccine policy is opaque and unfairly favours a company owned ...

Bristol, UK and Bangkok, Thailand, 23 rd September - eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, and Siam Bioscience, a leading biopharmaceutical ...

MANILA, June 1 (Reuters) - Delivery to the Philippines of the first batches of a promised 17 million doses of Thai-made AstraZeneca (AZN.L), opens new tab vaccines has been delayed by several weeks ...

eXmoor Pharma and Siam Bioscience, announced a strategic partnership to build the region’s foremost centre for Cell and Gene Therapy (CGT) development and manufacturing. The collaboration aims to ...

MANILA, June 1 (Reuters) - Delivery to the Philippines of the first batches of a promised 17 million doses of Thai-made AstraZeneca AZN.L vaccines has been delayed by several weeks and reduced in size ...